Precision CellSystems

Precision CellSystems, founded in 2015 and based in San Diego, CA, is a private company providing specialized instrumentation for the cell therapy and regenerative medicine sectors. The company addresses a critical bottleneck in life sciences by automating and standardizing the highly variable upstream steps of tissue dissociation and cell analysis, which are essential for reliable single-cell genomics and cell therapy manufacturing. Its core products—the Singulator automated tissue dissociator and the Moxi family of cell counters—are validated by peer-reviewed publications and are adopted by over 700 institutions globally. Precision CellSystems operates on a platform business model, generating revenue from instrument sales and consumables, and is positioned in the growing market for tools that enable reproducible and auditable cell processing.

Suite of automated instruments for cell sample preparation: the Singulator for automated tissue dissociation and the Moxi series for Coulter-principle cell counting and fluorescence phenotyping.

Precision CellSystems competes in specific niches against companies like Miltenyi Biotec (tissue dissociation) and a wide range of cell counter manufacturers (e.g., Bio-Rad, Nexcelom). Its differentiation lies in purpose-built, automated instruments focused on reproducibility, audit trails, and superior cell recovery, as validated in peer-reviewed studies.